Foghorn’s 2026 Layoffs: Biotech’s New Reality?
Foghorn Therapeutics cut 40% of its workforce in 2026. Is this a new trend for biotech? Understand why it happened and what it means for the industry.
Foghorn Therapeutics cut 40% of its workforce in 2026. Is this a new trend for biotech? Understand why it happened and what it means for the industry.
Helios Energy CEO Anya Sharma faced a 2026 challenge: pivot from crude oil to refined products? See why this investment shift matters.
Rising 10-year Treasury yields impact businesses. Learn how 4.6% yields affect borrowing, real estate, and corporate bonds by Q2 2026.
Horizon Manufacturing faces 15% stock dip. Learn how their 2026 TOYO Analyst Day plans to regain investor trust with new strategies.
Lululemon faces class-action lawsuits over $75 tariff refunds. Why customers feel overcharged and what this means for future retail pricing.
Alcohol sales are shifting towards premium drinks. Why are consumers paying more, and how will this trend reshape profits through 2026?
Canada's job market contracted for the third straight quarter in 2026. Unemployment hit 6.2%. See what sectors are hit and why it matters.
Biotech mergers fail 60% of the time. Learn why culture clashes and IT integration issues tank deals, costing billions. What's next for the industry?
E-commerce drives a $15B Latin American logistics boom. Learn how companies adapt supply chains for faster delivery and cold chain needs.
Ohio manufacturers are building regional hubs for 2026 growth. Learn how new facilities cut costs, attract investment, and secure supply chains.